Glucocorticoids Maintain Human Osteoclasts in the Active Mode of Their Resorption Cycle

被引:86
作者
Soe, Kent [1 ]
Delaisse, Jean-Marie [1 ]
机构
[1] Univ So Denmark, Vejle Hosp, Dept Clin Cell Biol, IRS CSFU, DK-7100 Vejle, Denmark
关键词
GLUCOCORTICOID; OSTEOCLAST; RESORPTION CYCLE; COLLAGEN DEGRADATION; MINERAL; ISOLATED RAT OSTEOCLASTS; BONE-RESORPTION; MATRIX METALLOPROTEINASES; RESORBING OSTEOCLASTS; INDUCED OSTEOPOROSIS; IN-VITRO; APOPTOSIS; CELLS; DIFFERENTIATION; INCREASE;
D O I
10.1002/jbmr.113
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Osteoclasts are known to exert their resorptive activity through a so-called resorption cycle consisting of alternating resorption and migration episodes and resulting typically in the formation of increasing numbers of discrete round excavations on bone slices. This study shows that glucocorticoids deeply modify this resorptive behavior. First, glucocorticoids gradually induce excavations with a trenchlike morphology while reducing the time-dependent increase in excavation numbers. This indicates that glucocorticoids make osteoclasts elongate the excavations they initiated rather than migrating to a new resorption site, as in control conditions. Second, the round excavations in control conditions contain undegraded demineralized collagen as repeatedly reported earlier, whereas the excavations with a trenchlike morphology generated under glucocorticoid exposure appear devoid of leftovers of demineralized collagen. This indicates that collagenolysis proceeds generally at a lower rate than demineralization under control conditions, whereas collagenolysis rates are increased up to the level of demineralization rates in the presence of glucocorticoids. Taking these observations together leads to a model where glucocorticoid-induced increased collagenolysis allows continued contact of osteoclasts with mineral, thereby maintaining resorption uninterrupted by migration episodes and generating resorption trenches. In contrast, accumulation of demineralized collagen, as prevails in controls, acts as a negative-feedback loop, switching resorptive activity off and promoting migration to a new resorption site, thereby generating an additional resorption pit. We conclude that glucocorticoids change the osteoclastic resorption mode from intermittent to continuous and speculate that this change may contribute to the early bone fragilization of glucocorticoid-treated patients. (C) 2010 American Society for Bone and Mineral Research.
引用
收藏
页码:2184 / 2192
页数:9
相关论文
共 47 条
[1]
A scrutiny of matrix metalloproteinases in osteoclasts:: evidence for heterogeneity and for the presence of MMPs synthesized by other cells [J].
Andersen, TL ;
Ovejero, MD ;
Kirkegaard, T ;
Lenhard, T ;
Foged, NT ;
Delaissé, JM .
BONE, 2004, 35 (05) :1107-1119
[2]
Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions [J].
Boissy, P. ;
Andersen, T. L. ;
Lund, T. ;
Kupisiewicz, K. ;
Plesner, T. ;
Delaisse, J. M. .
LEUKEMIA RESEARCH, 2008, 32 (11) :1661-1668
[3]
Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoclast differentiation [J].
Boissy, P ;
Andersen, TL ;
Abdallah, BM ;
Kassem, M ;
Plesner, T ;
Delaissé, JM .
CANCER RESEARCH, 2005, 65 (21) :9943-9952
[4]
Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone Density [J].
Bone, Henry G. ;
McClung, Michael R. ;
Roux, Christian ;
Recker, Robert R. ;
Eisman, John A. ;
Verbruggen, Nadia ;
Hustad, Carolyn M. ;
DaSilva, Carolyn ;
Santora, Arthur C. ;
Ince, B. Avery .
JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (05) :937-947
[5]
Glucocorticoid-induced osteoporosis: pathophysiology and therapy [J].
Canalis, E. ;
Mazziotti, G. ;
Giustina, A. ;
Bilezikian, J. P. .
OSTEOPOROSIS INTERNATIONAL, 2007, 18 (10) :1319-1328
[6]
Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis [J].
Carbonare, LD ;
Arlot, ME ;
Chavassieux, PM ;
Roux, JP ;
Portero, NR ;
Meunier, PJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (01) :97-103
[7]
CHAMBERS TJ, 1984, J CELL SCI, V70, P61
[8]
Osteoblastic 11β-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure [J].
Cooper, MS ;
Rabbitt, EH ;
Goddard, PE ;
Bartlett, WA ;
Hewison, M ;
Stewart, PM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (06) :979-986
[9]
Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis [J].
Dempster, DW ;
Moonga, BS ;
Stein, LS ;
Horbert, WR ;
Antakly, T .
JOURNAL OF ENDOCRINOLOGY, 1997, 154 (03) :397-406
[10]
Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis [J].
Dovio, A ;
Perazzolo, L ;
Osella, G ;
Ventura, M ;
Termine, A ;
Milano, E ;
Bertolotto, A ;
Angeli, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (10) :4923-4928